Search Jim Cramer's "Mad Money" trading recommendations using our exclusive "Mad Money" Stock Screener.
NEW YORK (TheStreet) -- It's the deals, or at least market buzz about deals, that gets investors excited, Jim Cramer told his Mad Money viewers Monday. Investors just can't get enough mergers and acquisitions it seems, and that's great news for potential targets and acquirers alike.
Case in point, Actavis (ACT), the company that recently acquired Allergan (AGN) for a hefty price that at the time drew many skeptics. Today, the combined company delivered a monster earnings beat, sending shares up a quick 3%. Cramer called the deal "genius," which is why he owns Actavis for his charitable trust, Action Alerts PLUS.
So what should investors make of the rumors that either Oracle (ORCL) or Microsoft (MSFT) may buy cloud king Salesforce.com (CRM)? Cramer didn't see Oracle being a good cultural fit for Salesforce but a Microsoft tie-up would make sense. Neither company is talking.